We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

178 hedge funds and large institutions have $661M invested in BioTelemetry, Inc. in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 20

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

29% more capital invested

Capital invested by funds: $512M → $661M (+$149M)

15% more call options, than puts

Call options by funds: $10.6M | Put options by funds: $9.19M

11% more funds holding

Funds holding: 160178 (+18)

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

Holders
178
Holders Change
+18
Holders Change %
+11.25%
% of All Funds
4.41%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
45
Increased
60
Reduced
55
Closed
20
Calls
$10.6M
Puts
$9.19M
Net Calls
+$1.37M
Net Calls Change
-$2.08M

BEAT Hedge Fund Activity: Q1 2017 in Review

178 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q1 2017, worth a combined $661M — up 29% from $512M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new BEAT positions and 20 closed out — a net gain of 25 holders — while 60 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock, adding an estimated $86.8M. The largest seller was Acadian Asset Management, cutting an estimated $7.07M.

  • 178 institutional investors held BioTelemetry, Inc. (BEAT) as of Q1 2017, up from 160 in Q4 2016.
  • Funds reported $661M of BioTelemetry, Inc. stock for Q1 2017, up 29% quarter-over-quarter.
  • 45 funds opened new BioTelemetry, Inc. positions in Q1 2017 and 20 closed out, a net change of +25 holders.
  • The largest BioTelemetry, Inc. buyer in Q1 2017 was BlackRock, an estimated $86.8M added.
  • The largest BioTelemetry, Inc. seller in Q1 2017 was Acadian Asset Management, an estimated $7.07M sold.

Based on aggregated 13F filings for Q1 2017.